Cataract Surgery

>

Latest News

Lupin receives FDA approval for Loteprednol Etabonate Ophthalmic Gel, 0.38%
Lupin receives FDA approval for Loteprednol Etabonate Ophthalmic Gel, 0.38%

July 3rd 2025

Lupin Limited secures FDA approval for Loteprednol Etabonate Ophthalmic Gel, enhancing treatment options for postoperative ocular inflammation and pain.

(Image credit: Wilmer Eye Institute/Johns Hopkins Medicine)
Wilmer Eye Institute marks 100 years: honoring the past, shaping the future

June 27th 2025

ForSight Robotics completes $125M Series B funding to address global surgeon shortage
ForSight Robotics completes $125M Series B funding to address global surgeon shortage

June 25th 2025

(Image courtesy of New York Eye and Ear Infirmary of Mount Sinai) Q&A: Kira Manusis, MD, on how the Center for Refractive Solutions is redefining patient care at NYEE
Q&A: Kira Manusis, MD, on how the Center for Refractive Solutions is redefining patient care at NYEE

June 23rd 2025

Ontario Health Coalition files formal complaints over illegal private clinic fees
Ontario Health Coalition files formal complaints over illegal private clinic fees

June 21st 2025

Video Interviews
Podcasts
EnVision Summit 2025: Advancing Ophthalmology and Optometry Together
EyePod: Transforming the MIGS pipeline into clinical practice
EYEPOD: Michael Rivers, MD, discusses the impact of Aetna's new policy requiring prior authorization for cataract surgery on ophthalmologists, their workflow, and patients.

More News

© 2025 MJH Life Sciences

All rights reserved.